Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

A specific genetic deletion in goats affects cashmere yield and thickness.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

No cure exists for alopecia areata, and treatments are personalized.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Ten miRNAs may play key roles in starting secondary hair follicle development in sheep foetuses.

Deucravacitinib helped a man regrow hair significantly.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

Standardizing light therapy methods could improve spinal cord injury treatment.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Periplaneta americana extract helps hair regrowth in mice with alopecia.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

JAK inhibition reduces autoimmune issues in Down syndrome.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Combining stem cells and organoids could improve skin regeneration treatments.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.